Global Diabetes Devices Industry

NEW YORK, Nov. 18, 2020 /PRNewswire/ -- Amid the COVID-19 crisis, the global market for Diabetes Devices estimated at US$24.7 Billion in the year 2020, is projected to reach a revised size of US$36.7 Billion by 2027, growing at aCAGR of 5.8% over the period 2020-2027. Monitoring and Diagnostic Devices, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$26.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Insulin Delivery Devices segment is readjusted to a revised 6% CAGR for the next 7-year period.

Read the full report: https://www.reportlinker.com/p05960876/?utm_source=PRN

The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 8.9% CAGR

The Diabetes Devices market in the U.S. is estimated at US$6.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.8 Billion by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.We bring years of research experience to this 6th edition of our report. The 180-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Medtronic PLC
• Novo Nordisk A/S
• Sanofi SA

Read the full report: https://www.reportlinker.com/p05960876/?utm_source=PRN

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Diabetes Devices Competitor Market Share Scenario Worldwide
(in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Diabetes Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 2: World Historic Review for Diabetes Devices by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 3: World 15-Year Perspective for Diabetes Devices by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Monitoring and
Diagnostic Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027

Table 5: World Historic Review for Monitoring and Diagnostic
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 6: World 15-Year Perspective for Monitoring and
Diagnostic Devices by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Insulin Delivery
Devices by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027

Table 8: World Historic Review for Insulin Delivery Devices by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 9: World 15-Year Perspective for Insulin Delivery Devices
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Diabetes Devices Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 10: USA Current & Future Analysis for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 11: USA Historic Review for Diabetes Devices by Segment -
Monitoring and Diagnostic Devices and Insulin Delivery Devices
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 12: USA 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

CANADA
Table 13: Canada Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 14: Canada Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 15: Canada 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

JAPAN
Table 16: Japan Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 17: Japan Historic Review for Diabetes Devices by Segment -
Monitoring and Diagnostic Devices and Insulin Delivery
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 18: Japan 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

CHINA
Table 19: China Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 20: China Historic Review for Diabetes Devices by Segment -
Monitoring and Diagnostic Devices and Insulin Delivery
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 21: China 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Diabetes Devices Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 22: Europe Current & Future Analysis for Diabetes Devices
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027

Table 23: Europe Historic Review for Diabetes Devices by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 24: Europe 15-Year Perspective for Diabetes Devices by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 25: Europe Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 26: Europe Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 27: Europe 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

FRANCE
Table 28: France Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 29: France Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 30: France 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

GERMANY
Table 31: Germany Current & Future Analysis for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 32: Germany Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 33: Germany 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

ITALY
Table 34: Italy Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 35: Italy Historic Review for Diabetes Devices by Segment -
Monitoring and Diagnostic Devices and Insulin Delivery
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 36: Italy 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

UNITED KINGDOM
Table 37: UK Current & Future Analysis for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 38: UK Historic Review for Diabetes Devices by Segment -
Monitoring and Diagnostic Devices and Insulin Delivery Devices
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 39: UK 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

SPAIN
Table 40: Spain Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 41: Spain Historic Review for Diabetes Devices by Segment -
Monitoring and Diagnostic Devices and Insulin Delivery
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 42: Spain 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

RUSSIA
Table 43: Russia Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 44: Russia Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 45: Russia 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

REST OF EUROPE
Table 46: Rest of Europe Current & Future Analysis for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 47: Rest of Europe Historic Review for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 48: Rest of Europe 15-Year Perspective for Diabetes
Devices by Segment - Percentage Breakdown of Value Sales for
Monitoring and Diagnostic Devices and Insulin Delivery Devices
for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 49: Asia-Pacific Current & Future Analysis for Diabetes
Devices by Geographic Region - Australia, India, South Korea
and Rest of Asia-Pacific Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027

Table 50: Asia-Pacific Historic Review for Diabetes Devices by
Geographic Region - Australia, India, South Korea and Rest of
Asia-Pacific Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019

Table 51: Asia-Pacific 15-Year Perspective for Diabetes Devices
by Geographic Region - Percentage Breakdown of Value Sales for
Australia, India, South Korea and Rest of Asia-Pacific Markets
for Years 2012, 2020 & 2027

Table 52: Asia-Pacific Current & Future Analysis for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 53: Asia-Pacific Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 54: Asia-Pacific 15-Year Perspective for Diabetes Devices
by Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

AUSTRALIA
Table 55: Australia Current & Future Analysis for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 56: Australia Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 57: Australia 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

INDIA
Table 58: India Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 59: India Historic Review for Diabetes Devices by Segment -
Monitoring and Diagnostic Devices and Insulin Delivery
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 60: India 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

SOUTH KOREA
Table 61: South Korea Current & Future Analysis for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 62: South Korea Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 63: South Korea 15-Year Perspective for Diabetes Devices
by Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

REST OF ASIA-PACIFIC
Table 64: Rest of Asia-Pacific Current & Future Analysis for
Diabetes Devices by Segment - Monitoring and Diagnostic Devices
and Insulin Delivery Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 65: Rest of Asia-Pacific Historic Review for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 66: Rest of Asia-Pacific 15-Year Perspective for Diabetes
Devices by Segment - Percentage Breakdown of Value Sales for
Monitoring and Diagnostic Devices and Insulin Delivery Devices
for the Years 2012, 2020 & 2027

LATIN AMERICA
Table 67: Latin America Current & Future Analysis for Diabetes
Devices by Geographic Region - Argentina, Brazil, Mexico and
Rest of Latin America Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027

Table 68: Latin America Historic Review for Diabetes Devices by
Geographic Region - Argentina, Brazil, Mexico and Rest of Latin
America Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 69: Latin America 15-Year Perspective for Diabetes
Devices by Geographic Region - Percentage Breakdown of Value
Sales for Argentina, Brazil, Mexico and Rest of Latin America
Markets for Years 2012, 2020 & 2027

Table 70: Latin America Current & Future Analysis for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 71: Latin America Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 72: Latin America 15-Year Perspective for Diabetes
Devices by Segment - Percentage Breakdown of Value Sales for
Monitoring and Diagnostic Devices and Insulin Delivery Devices
for the Years 2012, 2020 & 2027

ARGENTINA
Table 73: Argentina Current & Future Analysis for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 74: Argentina Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 75: Argentina 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

BRAZIL
Table 76: Brazil Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 77: Brazil Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 78: Brazil 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

MEXICO
Table 79: Mexico Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 80: Mexico Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 81: Mexico 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

REST OF LATIN AMERICA
Table 82: Rest of Latin America Current & Future Analysis for
Diabetes Devices by Segment - Monitoring and Diagnostic Devices
and Insulin Delivery Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 83: Rest of Latin America Historic Review for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 84: Rest of Latin America 15-Year Perspective for
Diabetes Devices by Segment - Percentage Breakdown of Value
Sales for Monitoring and Diagnostic Devices and Insulin
Delivery Devices for the Years 2012, 2020 & 2027

MIDDLE EAST
Table 85: Middle East Current & Future Analysis for Diabetes
Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE
and Rest of Middle East Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027

Table 86: Middle East Historic Review for Diabetes Devices by
Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of
Middle East Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019

Table 87: Middle East 15-Year Perspective for Diabetes Devices
by Geographic Region - Percentage Breakdown of Value Sales for
Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets
for Years 2012, 2020 & 2027

Table 88: Middle East Current & Future Analysis for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 89: Middle East Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 90: Middle East 15-Year Perspective for Diabetes Devices
by Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

IRAN
Table 91: Iran Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 92: Iran Historic Review for Diabetes Devices by Segment -
Monitoring and Diagnostic Devices and Insulin Delivery
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 93: Iran 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

ISRAEL
Table 94: Israel Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 95: Israel Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 96: Israel 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

SAUDI ARABIA
Table 97: Saudi Arabia Current & Future Analysis for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 98: Saudi Arabia Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 99: Saudi Arabia 15-Year Perspective for Diabetes Devices
by Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

UNITED ARAB EMIRATES
Table 100: UAE Current & Future Analysis for Diabetes Devices
by Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027

Table 101: UAE Historic Review for Diabetes Devices by Segment -
Monitoring and Diagnostic Devices and Insulin Delivery
Devices Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019

Table 102: UAE 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

REST OF MIDDLE EAST
Table 103: Rest of Middle East Current & Future Analysis for
Diabetes Devices by Segment - Monitoring and Diagnostic Devices
and Insulin Delivery Devices - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 104: Rest of Middle East Historic Review for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 105: Rest of Middle East 15-Year Perspective for Diabetes
Devices by Segment - Percentage Breakdown of Value Sales for
Monitoring and Diagnostic Devices and Insulin Delivery Devices
for the Years 2012, 2020 & 2027

AFRICA
Table 106: Africa Current & Future Analysis for Diabetes
Devices by Segment - Monitoring and Diagnostic Devices and
Insulin Delivery Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027

Table 107: Africa Historic Review for Diabetes Devices by
Segment - Monitoring and Diagnostic Devices and Insulin
Delivery Devices Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 108: Africa 15-Year Perspective for Diabetes Devices by
Segment - Percentage Breakdown of Value Sales for Monitoring
and Diagnostic Devices and Insulin Delivery Devices for the
Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 42
Read the full report: https://www.reportlinker.com/p05960876/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]   
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

www.reportlinker.com